Dr. Michael Kluger is a general surgeon in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Columbia University Irving Medical Center, NewYork-Presbyterian/Allen Hospital, and New York-Presbyterian/Hudson Valley Hospital. He received his medical degree from NYU Grossman School of Medicine and has been in practice 13 years. He specializes in hepatobiliary surgery, pancreas, and surgical oncology (other than breast) and is experienced in biliary tract disease, hepatocellular carcinoma, cholangiocarcinoma, gastrointestinal stromal tumors, and pancreatic cancer.
Office
161 Fort Washington Avenue Floor 8 New York, NY 10032
Recurrence of malignant peritoneal mesothelioma: Novel insights based on standardized second look procedures.
Heller D, Kluger MD, Greene A, Leinwand J, Bates GE, Chabot JA, Taub RN, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2015
Long-term outcomes of cytoreduction and HIPEC for malignant peritoneal mesothelioma.
Bates GE, Kluger MD, Jin Z, Chabot JA, Leinwand J, Bressler T, Rae M, Taub RN, Borczuk AC, Hesdorffer M, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2015
Irreversible electroporation is safe and feasible for the control and treatment of locally-advanced and borderline resectable pancreatic cancer: short-term results.
Winner M, Epelboym I, Kluger MD, Chabot JA, 48th Annual Pancreas Club Meeting, Chicago, IL, 1/1/2014
Central hepatectomy for centrally located liver malignancies: a safe alternative to extended hemihepatectomy.
Kluger MD, Lee SY, Laurent A, Azoulay D, Cherqui D, Society of Surgical Oncology 67th Annual Cancer Symposium, Phoenix, AZ, 1/1/2014
Central hepatectomy is a safe and technically feasible alternative to extended hepatectomy for centrally located primary and secondary liver malignancies.
Lee SY, Kluger MD, Belli A, Salceda JA, Tayar C, Laurent A, Azoulay D, Cherqui D, American College of Surgeons 2013 Annual Clinical Congress, Washington, DC, 1/1/2013
Salvage transplantation aligns survival for small and large hepatocellular carcinomas in the modern era of liver surgery.
Kluger MD, Salceda J, Laurent A, Tayar C, Azoulay D, Cherqui D, American Transplant Congress, Seattle, WA, 1/1/2013
Loss of deceased donor livers to technical and systems failures: a difficult determination with possibly easier solutions.
Kluger MD, Kluger A, Samstein B, Guarrera K, Kato T, Emond J, Cherqui D, American Transplant Congress, Seattle, WA, 1/1/2013
Stapling the cystic duct during laparoscopic cholecystectomy results in increased rates of unintended post-operative ERCP.
Epelboym I, Martin F, Winner M, Gleit Z, Kluger MD, Digestive Disease Week, Orlando, FL, 1/1/2013
Diagnostic radiation exposure during evaluation for liver transplantation.
Mooney M, Inra M, Kluger MD, Fox A, Olsen S, Cherqui D, American College of Surgeons 2012 Annual Clinical Congress, Chicago, IL, 1/1/2012
Bland- versus chemo-embolization of hepatocellular carcinoma prior to transplantation.
Kluger MD, Halazun K, Barroso R, Brubaker W, Zaretsky J, Siegel A, Susman J, Brown R, Cherqui D, Emond J, American Transplant Congress, Boston, MA, 1/1/2012
Liver resection for hepatocellular carcinoma: a western series of 313 patients.
Kluger MD, Salceda J, Laurent A, Tayar C, Duvoux C, Decaens T, Luciani A, Tran Van Nhieu J, Azoulay D, Cherqui D, 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, 1/1/2011
Influence of microscopic malignant peritoneal mesothelioma on posttreatment survival.
Kluger MD, Chabot JA. Hesdorffer ME, DeRosa CM, Taub RN, Journal of Clinical Oncology, 1/1/2009
Operative morbidity and mortality in 54 consecutive patients undergoing operative cytoreduction and intraperitoneal chemotherapy for peritoneal mesothelioma.
Kluger MD, Taub RN, Batista L, DeRosa CM, DiGiorgi M, Hesdorffer ME, Leinwand J, Chabot JA, Journal of Clinical Oncology, 1/1/2008
Irreversible electroporation (Nanoknife®) for pancreatic cancer: a single institution series of 50 consecutive patients.
Miami, FL - 1/1/2015
CT peritonography of dwell intraperitoneal chemotherapy for peritoneal mesothelioma.
Washington, DC - 1/1/2015
Recurrent malignant peritoneal mesothelioma causing massive gastrointestinal bleeding: not all histologies are stable or equal.
Clearwater Beach, FL - 1/1/2015
Signet Ring Carcinoma of the Pancreas: A Case Series of 621 Patients.
Las Vegas, NV - 1/1/2015
Perioperative considerations for pancreatic cancer.
New York, NY - 1/1/2015
Current management of hepatocellular carcinoma: from ablation to transplantation. The modern era.
Brooklyn, NY - 1/1/2015
I like to have a drink, so what? Pros and cons of consuming alcohol.
New York, NY - 1/1/2015
Neoadjuvant Chemoradiation for T4 Pancreatic Adenocarcinoma: A Gemcitabine, Docetaxel, and Capecitabine Protocol offers Superior Outcomes.
Washington, DC - 1/1/2015
Evaluation and management of benign liver lesions in the era of over-imaging.
Perth Amboy, NJ - 1/1/2014
Operative management of cystic neoplasms of the pancreas.
Mount Kisco, NY - 1/1/2014
Management of cholangiocarcinoma in the modern era.
Brooklyn, NY - 1/1/2014
Stage IV colorectal cancer: treating the causes of death.
New York, NY - 1/1/2014
Medical oncology perspective on the Columbia protocol: two-staged cytoreduction with intraperitoneal chemotherapy for malignant peritoneal mesothelioma.
Washington, DC - 1/1/2014
Cytoreduction with intraoperative and dwell intraperitoneal chemotherapy for malignant peritoneal mesothelioma: an intention to treat series.
Phoenix, AZ - 1/1/2014
Two-staged cytoreduction with intraperitoneal chemotherapy for malignant peritoneal mesothelioma.
New York, NY - 1/1/2013
Tumor size does not dictate prognosis after resection for hepatocellular carcinoma. results from a large western series.
Orlando, FL - 1/1/2013
Cholangiocarcinoma: current management strategies.
Queens, NY - 1/1/2013
Hepatocellular carcinoma: from ablation to transplantation and surgery in-between.
New York, NY - 1/1/2013
Hepatic resection versus laparoscopic radiofrequency ablation for very early hepatocellular carcinoma.
Rome, Italy - 1/1/2012
Hepatectomy for hepatocellulacr carcinoma in Child's A cirrhotic patients: is portal hypertension a contraindication?
Paris, France - 1/1/2012
How and why I got here: decision making on the path to residency and beyond.
Chicago, IL - 1/1/2012
Roundtables with Specialty Surgeons.
Chicago, IL - 1/1/2012
Non-colorectal, non-neuroendocrine liver metastases: can improved survival be on the horizon?
New York, NY - 1/1/2012
Liver resection for hepatocellular carcinoma: a western series of 313 patients.
Paris, France - 1/1/2012
Safety of blood group A2-to-O liver transplantation.
Aetna Choice POS II Aetna HMO BCBS Blue Card PPO BCBS California CaliforniaCare HMO BCBS California PPO Blue Shield CA Local Access Plus HMO Blue Shield California HMO Blue Shield California PPO CIGNA HMO CIGNA Open Access CIGNA PPO Empire BCBS HMO Empire BCBS PPO
First Health PPO GHI PPO Great West PPO Health Net California Large Group PPO Healthfirst New York HIP of New York - Select PPO Humana ChoiceCare Network PPO MVP Healthcare PPO Oxford Health Freedom Oxford Health Liberty Pacificare HMO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
New York Presbyterian Hospital (Columbia Campus)Chief Residency, Surgery, 2008 - 2009
New York University School of MedicineClass of 2004
Yale UniversityMPH, 1997 - 1999
CT State Medical License 2023 - 2025
NJ State Medical License 2022 - 2025
NY State Medical License 2005 - 2025
Scientists Find Trigger That Sets off Metastasis in Pancreatic CancerJune 28th, 2022
Pleural and Peritoneal Mesothelioma Combination Can Be ManagedJanuary 9th, 2020
